This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Jul;175(7):1169-70.

doi: 10.1001/jamainternmed.2015.1858.

Overuse of Bridging Anticoagulation for Patients With Venous Thromboembolism: First, Do No Harm

Daniel J Brotman¹, Michael B Streiff²

Affiliations

Affiliations

¹ Hospitalist Program, Division of General Internal Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland2Division of General Internal Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland.
² Division of Hematology, School of Medicine, The Johns Hopkins University, Baltimore, Maryland4Department of Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland.

PMID: 26011244
DOI: 10.1001/jamainternmed.2015.1858

Comment

Overuse of Bridging Anticoagulation for Patients With Venous Thromboembolism: First, Do No Harm

Daniel J Brotman et al. JAMA Intern Med. 2015 Jul.

. 2015 Jul;175(7):1169-70.

doi: 10.1001/jamainternmed.2015.1858.

Authors

Daniel J Brotman¹, Michael B Streiff²

Affiliations

¹ Hospitalist Program, Division of General Internal Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland2Division of General Internal Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland.
² Division of Hematology, School of Medicine, The Johns Hopkins University, Baltimore, Maryland4Department of Medicine, School of Medicine, The Johns Hopkins University, Baltimore, Maryland.

PMID: 26011244
DOI: 10.1001/jamainternmed.2015.1858

No abstract available

PubMed Disclaimer

Comment on

Bleeding, Recurrent Venous Thromboembolism, and Mortality Risks During Warfarin Interruption for Invasive Procedures.
Clark NP, Witt DM, Davies LE, Saito EM, McCool KH, Douketis JD, Metz KR, Delate T. Clark NP, et al. JAMA Intern Med. 2015 Jul;175(7):1163-8. doi: 10.1001/jamainternmed.2015.1843. JAMA Intern Med. 2015. PMID: 26010033

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems
Medical
- MedlinePlus Health Information